AMP:NYSEAmeriprise Financial, Inc. Analysis
Data as of 2026-03-10 - not real-time
$461.48
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ameriprise Financial shows a clear disconnect between its technical outlook and its underlying fundamentals. On the chart, price is trading below both short‑ and medium‑term moving averages, MACD is in a bearish configuration and volume is tapering, suggesting short‑term pressure toward the identified support zone. Yet the company delivers robust profitability, a trailing P/E well under the industry average, a strong ROE, and a low payout ratio that makes the dividend highly sustainable.
The valuation gap – with a discounted cash‑flow estimate far above the current market price – combined with solid cash generation and modest leverage points to a compelling buying opportunity for investors with a medium to long horizon. A disciplined approach that respects the near‑term support level while capitalizing on the undervaluation and dividend safety is advisable.
The valuation gap – with a discounted cash‑flow estimate far above the current market price – combined with solid cash generation and modest leverage points to a compelling buying opportunity for investors with a medium to long horizon. A disciplined approach that respects the near‑term support level while capitalizing on the undervaluation and dividend safety is advisable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical momentum with price below key moving averages
- Proximity to a defined support level
- Decreasing trading volume indicating limited short‑term buying pressure
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside relative to DCF fair value
- Strong return on equity and consistent cash flow generation
- Sustainable dividend supported by low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable competitive advantages in wealth and asset management
- Continued earnings growth potential and high profitability margins
- Attractive dividend yield combined with ample balance‑sheet strength
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin18.84%
P/E Ratio12.7
ROE60.51%
ROA2.27%
Debt/Equity57.60
P/B Ratio6.4
Op. Cash Flow$8.3B
Free Cash Flow$3.6B
Industry P/E17.4
Technical Analysis
TrendBearish
RSI40.9
Support$445.00
Resistance$545.35
MA 20$476.35
MA 50$495.95
MA 200$496.85
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair Value$834.55
Target Price$570.00
Upside/Downside23.52%
GradeUndervalued
TypeBlend
Dividend Yield1.39%
Risk Assessment
Beta1.17
Volatility38.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.